Diabetes
Reports from Kuwait, Belgium and Turkey advance knowledge in diabetes research
Published in Obesity and Diabetes Week, November 6th, 2006
Study 1: The degree of microalbuminuria is the most significant determinant of plasma erythropoietin in patients with type 2 diabetes mellitus.
"Low plasma erythropoeitin (EPO) is a key causal factor in the anaemia of diabetic patients. The aim of this study was to investigate the prevalence of anaemia in relation to EPO in patients with type 2 diabetes," researchers in Kuwait report.
O.A. Mojiminiyi and colleagues at Kuwait University described, "In a clinic-based cross-sectional study of 161 type 2 diabetes patients, we measured EPO, ferritin and full...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Insulin Resistance
Caloric restriction impacts insulin resistance after gastric banding and gastric bypass - Insulin Resistance
Insulin resistance after diet/exercise or pioglitazone is not likely related to adipokine levels - Obesity Complications
In obese, exercise restores muscle glucose delivery but not insulin-mediated glucose transport - Obesity Complications
Morbidly obese with impaired fasting glucose have specific insulin sensitivity pattern - Obesity Pathogenesis
In the muscle of obese, SOCS3 inhibits leptin activation of AMP-kinase - Obesity and Diabetes
Ben-Gurion University, Faculty of Health Sciences describes research in obesity and diabetes in adolescents - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
